Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $4.50
January 31, 2013 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Jan 31, 2013) - Vista Partners announced today that it has updated coverage on ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) ("ADVENTRX" or "ANX") with a twelve...